Patents by Inventor Davide Foletti

Davide Foletti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-IL1RAP ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20220106395
    Abstract: The present invention provides binding proteins, such as antibodies and antigen-binding fragments, which specifically bind to human interleukin-1 receptor accessory protein (hu-IL1RAP) and fully block the IL-1, IL-33, and IL-36 intracellular signaling pathways. Compositions comprising such binding proteins and methods of making and using such binding proteins are also provided.
    Type: Application
    Filed: September 27, 2021
    Publication date: April 7, 2022
    Applicant: 23andMe, Inc.
    Inventors: Davide Foletti, Erik Karrer, Germaine Fuh-KELLY, Kristie Ibarra, Quan Zheng, Yao-ming Huang, Lindsay Deis, Christine Wolak, Dominic Samuel Berns
  • Anti-IL1RAP antibodies
    Patent number: 11168140
    Abstract: The present invention provides binding proteins, such as antibodies and antigen-binding fragments, which specifically bind to human interleukin-1 receptor accessory protein (hu-IL1RAP) and fully block the IL-1, IL-33, and IL-36 intracellular signaling pathways. Compositions comprising such binding proteins and methods of making and using such binding proteins are also provided.
    Type: Grant
    Filed: August 15, 2019
    Date of Patent: November 9, 2021
    Assignee: 23andMe, Inc.
    Inventors: Davide Foletti, Erik Karrer, Germaine Fuh-Kelly, Kristie Ibarra, Quan Zheng, Yao-ming Huang, Lindsay Deis, Christine Wolak, Dominic Samuel Berns
  • ANTI-IL1RAP ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20200095328
    Abstract: The present invention provides binding proteins, such as antibodies and antigen-binding fragments, which specifically bind to human interleukin-1 receptor accessory protein (hu-IL1RAP) and fully block the IL-1, IL-33, and IL-36 intracellular signaling pathways. Compositions comprising such binding proteins and methods of making and using such binding proteins are also provided.
    Type: Application
    Filed: August 15, 2019
    Publication date: March 26, 2020
    Applicant: 23andMe, Inc.
    Inventors: Davide Foletti, Erik Karrer, Germaine Fuh, Kristie Ibarra, Quan Zheng, Yao-ming Huang, Lindsay Deis, Christine Wolak, Dominic Samuel Berns